[1]
W. A. Eneama, H. H. Salman, and M. N. Mousa, “Isoxazolidine Derivatives Exhibit Selective Antitumor Activity Against Breast Cancer Cells”, acopen, vol. 9, no. 2, p. 10.21070/acopen.9.2024.8148, Oct. 2023.